Technical analysis of Dermata Therapeutics, Inc. (DRMA): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Price Performance
| 1 month | -19.58% |
| 3 months | -1.71% |
| Year-to-date | -50.43% |
| 1 year | -79.39% |
| 3 years | -99.34% |
| 5 years | -99.99% |
52-Week Range
| 52-week High | $6.22 |
| 52-week Low | $0.95 |
| Avg Volume (90d) | 534K |
Technical Indicators
| SMA 50 | $1.30 |
| SMA 200 | $1.54 |
| 30-day Volatility (annualised) | 111.2% |
| Price vs SMA 50 | -11.3% |
| Price vs SMA 200 | -25.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $3.42 | |
| 2025-11 | $3.14 | -8.2% |
| 2025-12 | $2.32 | -26.1% |
| 2026-01 | $2.25 | -3.0% |
| 2026-02 | $1.20 | -46.7% |
| 2026-03 | $1.21 | +0.8% |
| 2026-04 | $1.37 | +13.2% |
| 2026-05 | $1.30 | -5.1% |
| 2026-06 | $1.29 | -0.8% |
| 2026-07 | $1.17 | -9.3% |
| 2026-08 | $1.29 | +10.3% |
| 2026-09 | $1.15 | -10.9% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $1.15 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.30 |
| EV / EBITDA | 0.42 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 2.81 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -14.56 |